AstraZeneca's Drug Combo To Treat Non-Small Cell Lung Cancer Stumbles In Late-Stage StudyBenzinga • 08/21/19
AstraZeneca's Latest Lung Cancer Data Sets It Apart Because Of Its Targeted Approach To TreatmentSeeking Alpha • 08/20/19
AstraZeneca PLC (AZN) CEO Pascal Soriot on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 07/25/19
Pharma Giants Top Second-Quarter Estimates, But Only One Stock PopsInvestors Business Daily • 07/25/19
Why Alzheimer's Treatment Hopes Endure Despite High-Profile Drug FailuresInvestors Business Daily • 06/14/19